How Deep Are the Risperdal Maker’s Pockets?

Philadelphia, PA:The Risperdal maker, Johnson & Johnson, was ordered July 1 to pay $70 million to a teenager who developed gynecomastia, which is the abnormal development of breasts in males. This latest lawsuit is surely a blow to the drug giant, especially because it is still facing more than 1,200 lawsuits nationwide, but mainly in Philadelphia